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Abstract
Background: Triptolide, an active compound of Radix Tripterygium wilfordii, is immunosuppressive,
cartilage protective and anti-inflammatory both in human and animal studies of various
inflammatory and autoimmune diseases, including rheumatoid arthritis, but its therapeutic
mechanism remains unclear. The aim of this study is to investigate the effects of triptolide on
cartilage cytokines in the CIA model.
Methods: Sprague Dawley rats were immunized with type II collagen and orally administered with
triptolide. The arthritic scores and incidence changes of the rats were observed. The expression
of TNF-α, IL-6, COX-2 and NF-κB in paw cartilage was studied with immunohistochemical staining.
Results: Triptolide, at both high and low doses, significantly lowered the arthritic scores, delayed
the onset of arthritis and lowered the arthritis incidence. Triptolide treatment at both high and low
doses lowered the expression of TNF-α, IL-6, COX-2 and NF-κB in paw cartilage in arthritic rats.
Conclusion: Triptolide lowers the arthritic scores, delays the onset of collagen induced arthritis
and reduces the expressions of TNF-α, IL-6, NF-κB and COX-2 in paw cartilage in arthritic rats.
Background
Rheumatoid arthritis (RA) is a chronic disease that affects
peripheral joints in human. It is characterized by inflam-
mation and cellular proliferation in the synovial lining of
joints, which can result in progressive destruction of carti-
lage and subchondral bones [1]. Tumor necrosis factor-α
(TNF-α), interleukin-6 (IL-6), cycloxygenase-2 (COX-2)
and nuclear factor κB (NF-κB) play important roles in the
disease progression of RA [2-5].
Current treatments for RA include disease modifying
antirheumatic drugs (DMARDs), non-steroidal anti-
inflammatory drugs (NSAIDs), steroid and biological
response modifiers which all aim to slow the disease pro-
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gression and prevent further joint damage. Patients on
these treatments may develop dependency on the medica-
tions and often suffer from side effects.
Triptolide is an active compound in the extract of Radix
Tripterygium wilfordii (Leigongteng) [6,7]. Triptolide is
immunosuppressive, cartilage protective and anti-inflam-
matory in vivo and effective on both humans and animals
inflicted by a range of inflammatory and autoimmune
diseases, such as RA [8-11]. The anti-inflammatory effects
of triptolide include the inhibition of IL-2 production in
mouse T cell hybridomas, inhibition of transcriptional
activation of NF-κB, suppression of NF-κB in T lym-
phocytes [12] and reduction of PGE2  production in
human monocytes and RA synovial fibroblasts [13]. An
earlier study showed that triptolide reduced the incidence
and severity of arthritis in collagen induced arthritis (CIA)
model [14]. The effects of triptolide on cartilage TNF-α,
IL-6, COX-2 and NF-κB are unclear; thus the present study
investigates the effects of triptolide on cartilage cytokines
in the rat CIA model, which is a widely used animal model
of inflammatory polyarthritis with similarities to RA, and
primarily mediated by an autoimmune response [15-18].
Methods
Animals
Sixty male Sprague Dawley rats of 8–10 weeks old (180–
200 g body weight) were purchased from the Center for
Laboratory Animal Care, Chinese Academy of Medical
Sciences. Rats were randomly divided into four groups:
(1) control, (2) CIA, (3) high dose triptolide (TH) and (4)
low dose triptolide (TL). Rats were housed in a tempera-
ture-, humidity- and light-controlled environment with
free access to rodent chow and water. The light-dark cycle
was 12 hours (light phase from 06:00 to 18:00). The
rodent license of the laboratory (NO. SYXK 11-00-0039)
was issued by the Science and Technology Ministry of
China. The approval of the Institutional Animal Ethics
Committee was obtained before animal experiments were
carried out.
Induction of CIA and evaluation of arthritis
Soluble pure rat type II collagen (CII) was from Rikard
Holmdahl (Lund University, Sweden) and complete Fre-
und's adjuvant was purchased from Sigma Corporation,
USA. CIA was induced by immunization once with 0.15
mg CII emulsified with equal complete Freund's adjuvant
at the foot. Since eight days after immunization, the
degree of arthritis was examined every two days. The
severity of arthritis was expressed as mean arthritic index
on a 0–4 scale according to the following criteria: 0- no
edema, 1- slight edema and erythema limited to the foot
and/or ankle, 2- slight edema and erythema from the
ankle to the tarsal bone, 3- moderate edema and erythema
from the ankle to the tarsal bone and 4- edema and ery-
thema from the ankle to the entire leg. Each limb was
graded and the maximum possible score was 16 for each
animal. A score of one or above was considered arthritic.
Treatment of CIA with triptolide
Triptolide (Huangshi Pharmaceutical Factory, China) was
orally administered to the rats for one week after immuni-
zation, once a day, lasting for three weeks, at 18.62 μg per
5 ml per kg of body weight (TH) and 9.31 μg per 5 ml per
kg of body weight (TL). The rats in the control and CIA
groups were administered with 5 ml of saline per kg of
body weight.
Immunohistochemistry
The expression of TNF-α, IL-6, COX-2 and NF-κB in hind
paw cartilage was determined with immunohistochemical
staining kits (Wuhan Boster Biotech, China). The staining
was performed in accordance with the product manual.
Briefly, on day 28 after the immunization, hind paws were
dissected, fixed in ice-cold 4% phosphate-buffered para-
formaldehyde (pH7.4), decalcified in cold by 10% ethyl-
enediamine tetraacetic acid (EDTA) in phosphate
buffered saline (PBS) and cryostat-sectioned at 6 μm. The
sections were fixed in cold acetone for ten minutes,
washed in PBS and depleted of endogenous peroxidase by
treatment with 0.3% H2O2 in absolute methanol for 15
minutes. After blocking nonspecific binding with 10%
normal rabbit serum in PBS for 30 minutes, the sections
were incubated with primary antibodies (rabbit anti-rat
TNF-α, IL-6, COX-2 and NF-κB antibodies) at appropriate
dilutions for one hour at 37°C, washed, incubated with
biotinylated goat anti-rabbit immunoglobulin G (IgG,),
washed and incubated with avidinbiotinylated horserad-
ish peroxidase complex (ABC) and diaminobenzidine tet-
rahydrochloride DAB (Elite kit, Vector Laboratories,
USA), then counterstained with hematoxylin. The positive
granule averages of three samples (6 scoops in each sam-
ple) in each section were determined by Q-win DC100
Image Analysis (Leica Microsystems, Germany). The per-
centage of positive granules in the whole screened area
was calculated.
Statistical analysis
Student-Newman-Keuls test was employed for variable
between groups when equal variances were assumed.
Dunnetts's t test for equal variances not assumed. Chi-
square test was employed for the incidence data analysis
(SPSS version 11.0). P values less than 0.05 were consid-
ered statistically significant.
Results
Effects of triptolide on arthritic scores and incidenceWe
used the CIA model in Sprague Dawley rats to investigate
the effects of triptolide on arthritis. The changes of arthri-
tis scores and arthritis incidence in the CIA and triptolideChinese Medicine 2009, 4:13 http://www.cmjournal.org/content/4/1/13
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treatment groups are shown in Figures 1 and 2 respec-
tively. CIA was developed in rats immunized with CII.
Clinical signs (e.g. periarticular erythema and edema) of
CIA first appeared in the paw on Day 10 after immuniza-
tion (Figure 1). Day 20 after immunization, the arthritic
scores started to decrease in the TH and TL groups
(3.229<t<4.750, P < 0.01 or P < 0.001). Oral administra-
tion of TL to arthritic rats reversed paw edema as did TH
(0<t<0.709, P  > 0.05). Triptolide delayed the onset of
arthritis (P < 0.01) and lowered arthritis incidence.
Effects of triptolide on proinflammatory cytokines, COX-2 
and NF-κB in cartilage
To investigate the actions of triptolide on CIA, we meas-
ured the levels of cartilage proinflammatory cytokines,
COX-2 and NF-κB in joints. Immunohistochemical stain-
ing of paraffin sections of the joints femoral and tibial
knee joint articular cartilage showed extensive positivity
for TNF-α, IL-6, COX-2 and NF-κB (Figures 3, 4, 5 and 6).
Positive cells markedly increased in the articular cartilage
in the CIA group, more so in the superficial than deep lay-
ers, while positive immunostaining for TNF-α, IL-6, COX-
2 and NF-κB in the control group was rare. In addition,
articular cartilage treated with triptolide in both TH and
TL groups showed limited and weak cytoplasmic staining
for TNF-α, IL-6, COX-2 and NF-κB, which means their
expression in superficial cartilage was lower than in that in
the CIA group (TH vs. CIA: TNF-α t = 3.514, P = 0.0015;
IL-6 t = 7.23, P < 0.001; COX-2 t = 3.152, P = 0.0038; NF-
κB t = 4.536 P < 0.001; TL vs. CIA: TNF-α t = 3.41, P =
0.0019; IL-6 t = 6.618, P < 0.001; COX-2 t = 2.915, P =
0.0400; NF-κB t = 5.135 P < 0.001). The results showed
that oral administration of TL to arthritic rats reduced the
levels of cartilage cytokines TNF-α, IL-6, COX-2 and NF-
κB as did TH (TNF-α t = 0.258, P = 0.7982; IL-6 t = 0.245,
P = 0.8082; cox2 t = 0.411, P = 0.6841; NF-κB t = 0, P =
1.000).
Discussion
RA is characterized by chronic inflammation in joints and
destruction of cartilage and bone. Pro-inflammatory
cytokines, such as TNF-α, IL-6, are closely associated with
this pathologic process. At inflammatory sites of RA, TNF-
α and IL-1 induce and/or enhance the production of pros-
taglandin E2 (PGE2) in synoviocytes and chondrocytes. IL-
6 synergistically augments the inflammatory action of IL-
1 in synoviocytes. The inflammatory actions of these
cytokines are dependent on NF-kB and so is the expres-
sion of COX-2, the rate-limiting enzyme for PGE2 biosyn-
thesis [2-5]. While previous studies focused on synovium
and synoviocytes, the studies on the expression of TNF-α,
IL-6, COX-2 and NF-κB in cartilage are lacking. The
present study focuses on the pro-inflammatory actions of
cytokines, i.e. the expression of TNF-α, IL-6 and NF-kB's
in cartilage, in a CIA rat model. Immunohistochemical
staining of the articular cartilage of the femoral and tibial
joint showed that the expression of TNF-α, IL-6, COX-2
and NF-κB markedly increased in the articular cartilage,
especially in its superficial layers. The present study shows
that articular cartilage and chondrocytes play important
roles in CIA.
Radix Tripterygium wilfordii, which demonstrated efficacy
on inflammatory and autoimmune diseases such as RA, is
immunosuppressive, cartilage protective and anti-inflam-
Arthritic scores after immunization with CII Figure 1
Arthritic scores after immunization with CII. Data are 
represented as mean ± standard deviation (SD). Since Day 20 
after immunization, the arthritic scores decreased in the trip-
tolide-treated rats at both high dosage and low dosage (*P < 
0.01 and **P < 0.001 vs. CIA group).
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Arthritic incidence of CIA in rats after immunization with CII Figure 2
Arthritic incidence of CIA in rats after immunization 
with CII. Triptolide delayed the onset of arthritis (*P < 0.01 
vs. CIA group).
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Effects of triptolide on the expression of TNF-α in paw cartilage in the CIA group Figure 3
Effects of triptolide on the expression of TNF-α in paw cartilage in the CIA group. Paraffin sections of the joints 
were collected and subjected to immunohistochemical staining. TNF-α positive cells were stained in brown (hematoxylin coun-
terstain). Data are represented as the mean ± SD (*P < 0.001 vs. control group; ##P < 0.01 vs. CIA group). (× 400).
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Effects of triptolide on the expression of IL-6 in paw cartilage in the CIA group Figure 4
Effects of triptolide on the expression of IL-6 in paw cartilage in the CIA group. Paraffin sections of the joints were 
collected and subjected to immunohistochemical staining. The IL-6 positive cells were stained in brown (hematoxylin counter-
stain). Data are represented as the mean ± SD (*P < 0.001 vs. control group; ###P < 0.001 vs. CIA group). (× 400).
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Effects of triptolide on the expression of COX-2 in paw cartilage in the CIA group Figure 5
Effects of triptolide on the expression of COX-2 in paw cartilage in the CIA group. Paraffin sections of the joints 
were collected for immunohistochemical staining. The Cox-2 positive cells were stained in brown (hematoxylin counterstain). 
Data are represented as the mean ± SD (*P < 0.001 vs. control group; ##P < 0.05, #P < 0.01 vs. CIA group). (× 400).
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Effects of triptolide on the expression of NF-κB in paw cartilage of CIA rats Figure 6
Effects of triptolide on the expression of NF-κB in paw cartilage of CIA rats. Paraffin sections of the joints were col-
lected and subjected to immunohistochemical staining. The NF-κB positive cells were stained in brown (hematoxylin counter-
stain). Data are represented as the mean ± SD (*P < 0.001 vs. control group; ##P < 0.001 vs. CIA group). (× 400).
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matory in vivo [19-24]. Triptolide is an active compound
of Radix Tripterygium wilfordii and the anti-inflammatory
effects of triptolide are achieved through the inhibition of
NO production and iNOS expression through blockade of
NF-κB and Jun N-terminal kinases (JNK) activation
[16,25], inhibition of the proliferation of lymphocytes
[17], down-regulation of TNF-α-induced COX-2 and pro-
duction of PGE2 [18]. In the present study, we demon-
strated that triptolide, at both high dose and low dose,
significantly lowered the arthritic scores, delayed the
onset of arthritis and lowered the arthritis incidence. Trip-
tolide, at both high dose and low dose, lowered the
expression of TNF-α, IL-6, COX-2 and NF-κB in cartilage
in the CIA group. Triptolide, therefore, may have the
potential to protect cartilage in patients of RA.
Conclusion
Triptolide lowers the arthritic scores, delays the onset of
CIA and reduces the expressions of TNF-α, IL-6, NF-κB
and COX-2 in paw cartilage in rats.
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